Idorsia Ltd ( IDRSF) - Key Metrics
IDRSF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.21 | -$0.42 | -$0.13 | -$0.14 |
| 2026Q1 | $0.23 | -$0.18 | -$0.11 | -$0.11 |
| 2025Q4 | $0.19 | -$0.31 | -$0.17 | -$0.19 |
| 2025Q3 | $0.19 | -$0.40 | -$0.10 | -$0.10 |
| 2025Q2 | $0.38 | -$0.06 | -$0.19 | -$0.24 |
IDRSF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.56 |
| 2026Q1 | 0% | -4.54 |
| 2025Q4 | 0% | -3.25 |
| 2025Q3 | 0% | -2.29 |
| 2025Q2 | 0% | -7.90 |
IDRSF
Price: $7.31
52 week price:
Earnings Per Share: -1.11 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.8 billion